RxSight (RXST) Capital Expenditures (2020 - 2026)
RxSight's (RXST) quarterly Capital Expenditures came in at $759000.0 in Q1 2026, up 272.06% YoY from $204000.0 in Q1 2025, and up 165.38% on a QoQ basis from $286000.0 in Q4 2025.
RxSight (RXST) Capital Expenditures (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Capital Expenditures data on file, last reported at $759000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 272.06% year-over-year to $759000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $976000.0 (down 73.46% YoY) and the FY2025 annual result came in at $421000.0, down 92.26% from the prior year.
- Capital Expenditures rose to $759000.0 in Q1 2026, from $286000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.8 million in Q3 2023 to a low of -$2.0 million in Q3 2025.
- A 5-year average of $690176.5 and a median of $759000.0 in 2026 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 1155.07% — and 2024, when it soared 922.15%.
- Tracing RXST's Capital Expenditures over 5 years: stood at -$1.7 million in 2022, then surged by 191.86% to $1.6 million in 2023, then plunged by 46.76% to $847000.0 in 2024, then slumped by 66.23% to $286000.0 in 2025, then jumped by 165.38% to $759000.0 in 2026.
- The last three Capital Expenditures figures came in at $759000.0 (Q1 2026), $286000.0 (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.79 Bn | 195.19 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.96 Bn | 122.49 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.43 Bn | 109.21 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.13 Bn | 72.59 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.63 Bn | 47.38 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.17 Bn | 22.85 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 87.50 Mn |
| 10 | RxSight | 251.85 Mn | -152.40 Mn | - | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Mn |
| Jun 30, 2026 | 1.96 Mn |
| Mar 31, 2026 | 759,000.00 |
| Mar 31, 2026 | 759,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | -1.98 Mn |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 204,000.00 |
| Mar 31, 2025 | 204,000.00 |
| Dec 31, 2024 | 847,000.00 |
| Dec 31, 2024 | 847,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.97 Mn |